Current clinical trials
An alphabetical list of all clinical trials currently being undertaken by Sheffield Dermatology Research.
If you’re interested in taking part in our studies, get in touch:
- Email: skinresearch@sheffield.ac.uk
- Tel: +44 114 215 9539
You can also fill in our volunteer registration form
B
BARRIER
Effect of a barrier repair cream on the skin
- Funder: Hyphens
- Status: RECRUITMENT PAUSED
- Contact: skinresearch@sheffield.ac.uk
BEPAIR
Study on the effects of emollients on the skin.
- Status: CLOSED
- Contact: oskatibi1@sheffield.ac.uk
BOND
Barrier Optimising skincare for Newborn Development
A randomised controlled trial of a specially designed wash product and lotion for the maintenance of healthy skin and mind in babies (Phase 1 & 2)
- Funder: Johnson & Johnson
- Status: CLOSED
- Contact: BOND@sheffield.ac.uk
BRaCE
An investigation of the skin Barrier Reinforcing effects of a cream containing Ceramides in a multi vesicular emulsion in people with dry, Eczema-prone, skin
- Status: CLOSED
- Contact: skinresearch@sheffield.ac.uk
C
COSMOS
Characterisation Of Skin MicrOstructure under normal and atrophied States
- Status: OPEN
- Contact: hhalfailakawi1@sheffield.ac.uk
O
Open-label Study of Dupilumab (REGN668) in Paediatric Patients With Atopic Dermatitis
An open-label extension study to assess the long-term safety and efficacy of dupilumab in patients’ ≥6 to <18 years of age with Atopic dermatitis R668-AD-1434. (Liberty-OLE)
- Funder:
- Status:
- Contact:
P
PELISTAD
(PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis)
Open-label exploratory study to evaluate the effect of Dupilumab on skin barrier function in pediatric patients with moderate-to-severe atopic dermatitis.
- Funder: Sanofi
- Status: OPEN
- Contact: laura.johnson80@nhs.net/rebecca.smith251@nhs.net
PELISTAD - Extension
(PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis - Extension)
Open-label exploratory study to evaluate the effect of Dupilumab on skin barrier function in pediatric patients with moderate-to-severe atopic dermatitis.
- Funder: Sanofi
- Status: OPEN
- Contact: laura.johnson80@nhs.net/rebecca.smith251@nhs.net
S
SMART 1
Skin bioMARkers for atopic eczema Therapy evaluation - Study 1
Validation of a novel composite of skin biomarkers as a primary outcome measure for evaluating the safety of treatments for atopic dermatitis.
- Funder: Pfizer
- Status: CLOSED
- Contact: skinresearch@sheffield.ac.uk
SMART 2
Skin bioMARkers for atopic eczema Therapy evaluation - Study 2
Validation of a novel composite of skin biomarkers as a primary outcome measure for evaluating the safety of treatments for atopic dermatitis.
- Funder: Pfizer
- Status: CLOSED
- Contact: skinresearch@sheffield.ac.uk
SPOT
Skin Pathology assessment with Optical Technologies
A cross-sectional clinical study in atopic dermatitis patients and healthy subjects.
- Funder: LEO Pharmaceuticals
- Status: CLOSED
- Contact: spotstudy@sheffield.ac.uk
STAR
Skin Testing for Atopic eczema Risk
A longitudinal investigation of skin barrier development from birth and the validation of early predictors of AD risk.
- Funder: The LEO Foundation
- Status: COMPLETED
- Contact: starstudy@sheffield.ac.uk
SUDS
Analysis of SLS Uptake in Atopic Dermatitis patients using Fourier Transform Infrared Spectroscopy
- Funder: EPSRC
- Status: CLOSED
- Contact: +44 114 215 9539